Clinical trials
Phase 3 Peripheral Arterial Disease trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 2 |
| Eli Lilly and Company | 2 |
| AstraZeneca | 1 |
| Boston Scientific Corporation | 1 |
| CSL Behring | 1 |
| Hoffmann-La Roche | 1 |
| McMaster University | 1 |
| Novo Nordisk A/S | 1 |
| Population Health Research Institute | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peripheral Arterial Disease | 12 |
| Atherosclerosis | 3 |
| Cardiovascular Diseases | 3 |
| Coronary Artery Disease | 3 |
| Heart Diseases | 3 |
| Stroke | 3 |
| Atrial Fibrillation | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Heart Valve Diseases | 2 |
| Myocardial Infarction | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.